CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
2.340
+0.060 (2.63%)
At close: Sep 5, 2025, 4:00 PM
2.300
-0.040 (-1.71%)
After-hours: Sep 5, 2025, 6:13 PM EDT

CASI Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
36449524112366
Upgrade
Market Cap Growth
-74.41%-54.03%291.63%-78.22%-69.41%22.81%
Upgrade
Enterprise Value
4742811776313
Upgrade
Last Close Price
2.282.837.161.798.0029.50
Upgrade
PS Ratio
1.181.542.820.563.7124.15
Upgrade
PB Ratio
-23.693.950.361.043.53
Upgrade
P/TBV Ratio
-27.184.270.561.555.35
Upgrade
EV/Sales Ratio
1.501.482.400.402.5120.66
Upgrade
Debt / Equity Ratio
-0.9211.960.880.020.020.03
Upgrade
Asset Turnover
0.770.440.400.370.230.13
Upgrade
Inventory Turnover
2.071.651.263.947.703.22
Upgrade
Quick Ratio
0.320.862.453.784.438.90
Upgrade
Current Ratio
0.481.093.554.324.709.28
Upgrade
Return on Equity (ROE)
--301.80%-57.65%-46.04%-33.89%-48.18%
Upgrade
Return on Assets (ROA)
-62.73%-38.01%-18.43%-14.12%-16.55%-18.08%
Upgrade
Return on Capital (ROIC)
-186.63%-70.63%-27.80%-18.56%-20.30%-20.55%
Upgrade
Earnings Yield
-132.75%-89.54%-28.24%-168.40%-32.77%-13.21%
Upgrade
FCF Yield
--67.16%-21.15%-109.63%-32.00%-7.49%
Upgrade
Buyback Yield / Dilution
-21.99%-14.82%2.10%-0.27%-23.23%-15.12%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q